These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells. Shiohara T, Mizukawa Y. Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380 [Abstract] [Full Text] [Related]
4. The immunological basis of lichenoid tissue reaction. Shiohara T, Mizukawa Y. Autoimmun Rev; 2005 Apr; 4(4):236-41. PubMed ID: 15893718 [Abstract] [Full Text] [Related]
7. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells. Mizukawa Y, Shiohara T. Curr Allergy Asthma Rep; 2009 Jan; 9(1):71-7. PubMed ID: 19063828 [Abstract] [Full Text] [Related]
8. Role of T cells in nonimmediate allergic drug reactions. Rozieres A, Vocanson M, Saïd BB, Nosbaum A, Nicolas JF. Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):305-10. PubMed ID: 19474707 [Abstract] [Full Text] [Related]
9. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization. Teraki Y, Shiohara T. Dermatology; 2004 Aug; 209(1):29-32. PubMed ID: 15237264 [Abstract] [Full Text] [Related]
14. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. Akdis M, Simon HU, Weigl L, Kreyden O, Blaser K, Akdis CA. J Immunol; 1999 Jul 01; 163(1):466-75. PubMed ID: 10384150 [Abstract] [Full Text] [Related]
15. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients. Takahashi N, Matsumoto K, Saito H, Nanki T, Miyasaka N, Kobata T, Azuma M, Lee SK, Mizutani S, Morio T. J Immunol; 2009 May 01; 182(9):5515-27. PubMed ID: 19380800 [Abstract] [Full Text] [Related]
16. The immune system in extreme longevity. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, Telera A, Lucchini G, Passeri G, Monti D, Franceschi C, Passeri M. Exp Gerontol; 2008 Feb 01; 43(2):61-5. PubMed ID: 17870272 [Abstract] [Full Text] [Related]
17. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. Teraki Y, Shiohara T. J Allergy Clin Immunol; 2003 Sep 01; 112(3):609-15. PubMed ID: 13679823 [Abstract] [Full Text] [Related]
18. Murine CD8+ regulatory T lymphocytes: the new era. Pomié C, Ménager-Marcq I, van Meerwijk JP. Hum Immunol; 2008 Nov 01; 69(11):708-14. PubMed ID: 18817827 [Abstract] [Full Text] [Related]
19. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Blanco P, Pitard V, Viallard JF, Taupin JL, Pellegrin JL, Moreau JF. Arthritis Rheum; 2005 Jan 01; 52(1):201-11. PubMed ID: 15641052 [Abstract] [Full Text] [Related]
20. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes. Baadsgaard O, Fox DA, Cooper KD. J Immunol; 1988 Mar 15; 140(6):1738-44. PubMed ID: 2964481 [Abstract] [Full Text] [Related] Page: [Next] [New Search]